乳腺“干细胞(CK5/6^+)学说”与导管上皮良恶性增生的诊断
被引量:3
摘要
一、乳腺“干细胞学说”与导管上皮良恶性增生的组织发生传统上认为乳腺上皮由2种细胞组成:腔缘腺上皮细胞及肌上皮细胞。由此认为:乳腺普通型增生与乳腺癌的发生是由乳腺腔缘上皮细胞不同程度的分化所致,是一个连续的组织学谱系,即都源自腔缘上皮,由增生→不典型增生→癌变,最后演化成浸润性乳腺癌。
出处
《中华病理学杂志》
CAS
CSCD
北大核心
2013年第2期73-77,共5页
Chinese Journal of Pathology
参考文献12
-
1Bodian CA,Perzin KH,Lattes R. Reproducibility and validity of pathologic classifications of benign breast disease and implications for clinical applications[J].Cancer,1993,(12):3908-3913.
-
2Dupont WD,Page DL. Risk factors for breast cancer in women with proliferative breast disease[J].New England Journal of Medicine,1985,(03):146-151.
-
3Boecker W,Buerger H,Schmitz K. Ductal epithelial proliferations of the breast:a biological continuum? Comparative genomic hybridization and high-molecular-w-eight cytokeratin expression patterns[J].Journal of Pathology,2001,(04):415-421.
-
4Boecker W,Moll R,Dervan P. Usual ductal hyperplasia of the breast is a committed stem(progenitor)cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ[J].Journal of Pathology,2002,(04):458-467.
-
5Boecker W,Moll R,Poremba C. Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages:a new cell biological concept[J].Laboratory Investigation,2002,(06):737-746.
-
6Clarke CL,Sandle J,Parry SC. Cytokeratin 5/6 in normal human breast:lack of evidence for a stem cell phenotype[J].Journal of Pathology,2004,(02):147-152.doi:10.1002/path.1647.
-
7Koerner FC. Diagnostic problems in breast pathology[M].Philadelphia:WB Saunders,2009.15-83.
-
8Dabbs DJ. Breast pathology[M].Philadelphia:WB Saunders,2012.332-346.
-
9Bánkfalvi A,Ludwig A,De-Hesselle B. Different proliferative activity of the glandular and myoepithelial lineages in benign proliferative and early malignant breast diseases[J].Modern Pathology,2004,(09):1051-1061.doi:10.1038/modpathol.3800082.
-
10Otterbach F,Bànkfalvi A,Bergner S. Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast[J].Histopathology,2000,(03):232-240.
同被引文献14
-
1于志勇,于金明,吴泰璜,卓培英,王圣芳,李美,张霞,吕宝玉,刘雁冰.乳腺癌分子生物学特性检测的临床意义[J].中华肿瘤杂志,2005,27(7):420-422. 被引量:14
-
2Gostarelli L, Campagna D, Mauri M, et al. Intraductal proliferative lesiom of the breast-terminology and biology matter: premalignant lesions or preinvasive cancer? [ J]. Int J Surg Oncol, 2012, 2012:501904.
-
3Simpson J F, Schnitt S J, Visscher D, et al. Atypical ductal hyperplasia[ M //Lakhani SR, Ellis I0, Schnitt SJ, et al. WHO classification of tumours of the breast and female genital organs. 4th ed. Lyon: IARC Press, 2012: 88-89.
-
4B6cker W, Hungermann D, Decker T. Anatomy of the breast [ J ]. Pathologe, 2009, 30(1) :6-12.
-
5Boecker W, Buerger H. Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium : a new progenitor ( adult stem) cell concept [ J ]. Cell Prolif, 2003, 36(Suppl) 1:73-84.
-
6MacGrogan G, Arnould L, de Mascarel I, et al. Impact of immuno- histochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions [ J 1. Histopathology, 2008, 52(6) :689-697.
-
7Moriya T, Kasajima A, Ishida K, et al. New tretMs ff ihistcchenstry for making differential diagnosis of breast lesions [ J ]. Med Mol Morphol, 2006, 39(1):8-13.
-
8Jain RK, Mehta R, Dimitmv R, et al. Atypical ductal hyperplasia: intembserver and intraobserver variability [ J ]. Mod Pathol, 2011, 24(7) :917-923.
-
9Li L, Wang Q, Lv X, et al. Expression and localization of estrogen receptor in human breast cancer and its clinical significance [ J ]. Cell Biochem Biophys, 2015, 71 ( 1 ) :63-68.
-
10Shaaban AM, Sloane JP, West CR, et al. Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression [ J ]. Am J Patho|, 2002, 160 (2) : 597-604.
引证文献3
-
1牛凤婷,王丽,张巍,吕淑华,牛昀.CK56CK14雌激素受体和孕激素受体检测在乳腺导管内增生性病变辅助诊断中的应用[J].中华肿瘤杂志,2015,37(10):749-752. 被引量:3
-
2赵可,钱建忠,徐洪明.免疫组织化学在乳腺普通型与不典型导管增生诊断中的意义[J].山西医药杂志,2018,47(12):1389-1391. 被引量:1
-
3王星星,胡勇,夏国栋,李梦君.CD44^+/CD24^-和CK5/6在乳腺浸润性导管癌、乳腺普通型导管增生和低级别导管原位癌中的表达[J].中国组织化学与细胞化学杂志,2015,23(5):413-418.
二级引证文献4
-
1赵可,钱建忠,徐洪明.免疫组织化学在乳腺普通型与不典型导管增生诊断中的意义[J].山西医药杂志,2018,47(12):1389-1391. 被引量:1
-
2毛岸云,陈茂剑,杨春,欧超,叶新青,覃庆洪,莫淼,韦长元.两种7,12-二甲基苯蒽给药方式诱导树鼩乳腺癌动物模型的建模效果比较[J].中华肿瘤杂志,2019,41(5):346-350.
-
3程化朋,魏蕾.免疫组织化学检测在乳腺病理诊断中的应用价值[J].系统医学,2020,5(5):19-21. 被引量:6
-
4韦拔雄,彭婧,陈月禄,廖红兴,钟晓华,陈碧君.乳腺导管增生性病变中CK5/6、P63、CK8/18、SMA、ER的表达意义[J].当代医学,2020,26(34):106-108. 被引量:1
-
1陈骅,黄强,董军,兰青.肿瘤起源细胞学说与争论[J].癌症,2006,25(6):779-784. 被引量:17
-
2陈定宝,沈丹华,阚秀.乳腺干细胞研究进展[J].中华病理学杂志,2007,36(6):423-425. 被引量:1
-
3马文浩,韩玉贞.乳腺癌干细胞信号转导通路的研究进展[J].医学综述,2011,17(18):2759-2762. 被引量:3
-
4张斌,翟保平,李文涛.乳腺癌干细胞的研究现状[J].河南医学研究,2010,19(4):496-500.
-
5张松灵,费军伟,王毅.宫颈癌干细胞的研究进展[J].中国妇幼保健,2010,25(13):1872-1874. 被引量:4
-
6张众,李连宏,谢丰培.乳腺干细胞与乳腺癌干细胞研究及其临床意义[J].临床与实验病理学杂志,2008,24(1):6-11. 被引量:9
-
7范瑞华,李惠民,李晓进,喻镁佳,金从国.白血病细胞系K562侧群细胞的分选及其初步研究[J].中华血液学杂志,2010,31(6):418-420. 被引量:1
-
8康健豪,杨光,赵世光.肿瘤干细胞与肿瘤微环境的相互作用[J].临床神经外科杂志,2013,10(6):380-382. 被引量:1
-
9周隽,吴强,杨枫.乳腺癌中PTEN表达及其临床病理意义[J].临床与实验病理学杂志,2003,19(2):162-164. 被引量:12
-
10刘婷婷,李学锋,王丽,陈玥,潘鑫艳,宋蜀伶,杨丽琳,崔静,杨举伦.CD133^+细胞在乳腺良恶性病变中的分布特点及其临床病理意义[J].中国肿瘤临床,2011,38(19):1196-1200.